Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
76 hedge funds and large institutions have $380M invested in Alpine Immune Sciences Inc in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 2 closing their positions.
800% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 2
183% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 12
42% more capital invested
Capital invested by funds: $268M → $380M (+$113M)
27% more funds holding
Funds holding: 60 → 76 (+16)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$8.25M |
| 2 |
BlackRock
New York
|
+$6.57M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.08M |
| 4 |
TLP
Tri Locum Partners
New York
|
+$2.99M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$2.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.63M |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$4.2M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$4.08M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.4M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$1.16M |
ALPN Hedge Fund Activity: Q2 2023 in Review
76 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2023, worth a combined $380M — up 42% from $268M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ALPN positions and 2 closed out — a net gain of 16 holders — while 34 added to existing stakes and 12 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $8.25M. The largest seller was BVF Inc, exiting entirely with an estimated $6.63M sold.
- 76 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2023, up from 60 in Q1 2023.
- Funds reported $380M of Alpine Immune Sciences Inc stock for Q2 2023, up 42% quarter-over-quarter.
- 18 funds opened new Alpine Immune Sciences Inc positions in Q2 2023 and 2 closed out, a net change of +16 holders.
- The largest Alpine Immune Sciences Inc buyer in Q2 2023 was Vivo Capital, an estimated $8.25M added.
- The largest Alpine Immune Sciences Inc seller in Q2 2023 was BVF Inc, an estimated $6.63M sold.
Based on aggregated 13F filings for Q2 2023.